<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: ACTI.ST News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=acti.st</link><description>Latest Financial News for ACTIVE BIOTECH</description><language>en-us</language><lastBuildDate>Mon, 14 Dec 2009 07:43:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Primary endpoint reached in Active Biotech&apos;s TASQ Phase II clinical trial in prostate cancer patients (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091214/0568552.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2098566356</guid><pubDate>Mon, 14 Dec 2009 07:43:00 Etc/GMT</pubDate></item><item><title>Q3 2009 Active Biotech AB Earnings Release - Time Not Supplied (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091105.html?t=acti.st</link><description></description><guid isPermaLink="false">yahoo_finance/1427286236</guid><pubDate>Thu, 5 Nov 2009 12:07:21 Etc/GMT</pubDate></item><item><title>Active Biotech&apos;s election committee appointed (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091105/0555676.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2878423148</guid><pubDate>Thu, 5 Nov 2009 07:40:00 Etc/GMT</pubDate></item><item><title>Active Biotech AB Interim Report, January - September 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091105/0555675.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/771667455</guid><pubDate>Thu, 5 Nov 2009 07:38:00 Etc/GMT</pubDate></item><item><title>RhuDex Clinical Development to Continue Following Feedback from Regulatory Authorities (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091005/0543948.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1805928442</guid><pubDate>Mon, 5 Oct 2009 09:30:00 Etc/GMT</pubDate></item><item><title>Active Biotech to Present at the UBS Global Life Sciences Conference (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090917/0538176.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3327561780</guid><pubDate>Thu, 17 Sep 2009 12:10:00 Etc/GMT</pubDate></item><item><title>Laquinimod presentations at ECTRIMS (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090908/0534774.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3580659544</guid><pubDate>Tue, 8 Sep 2009 14:45:00 Etc/GMT</pubDate></item><item><title>Active Biotech to Present at the Rodman &amp; Renshaw 11th Annual Healthcare Conference (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090904/0534204.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/557316088</guid><pubDate>Fri, 4 Sep 2009 06:30:00 Etc/GMT</pubDate></item><item><title>New information regarding RhuDex(TM) (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090807/0525974.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/52024594</guid><pubDate>Fri, 7 Aug 2009 14:55:00 Etc/GMT</pubDate></item><item><title>Active Biotech AB Interim report January-June 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090806/0525605.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2361312348</guid><pubDate>Thu, 6 Aug 2009 17:20:00 Etc/GMT</pubDate></item><item><title>Active Biotech&apos;s Cancer Project ANYARA Featured in Journal of Clinical Oncology (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090728/0522600.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3492677551</guid><pubDate>Tue, 28 Jul 2009 06:37:00 Etc/GMT</pubDate></item><item><title>Number of shares and votes in Active Biotech (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090630/0515163.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/3385625518</guid><pubDate>Tue, 30 Jun 2009 06:30:00 Etc/GMT</pubDate></item><item><title>Active Biotech&apos;s rights issue substantially oversubscribed (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090615/0510501.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/900945598</guid><pubDate>Mon, 15 Jun 2009 06:30:00 Etc/GMT</pubDate></item><item><title>Active Biotech Presents Data regarding the 57-57 SLE Project at EULAR (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090611/0509733.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3881053706</guid><pubDate>Thu, 11 Jun 2009 06:30:00 Etc/GMT</pubDate></item><item><title>Active Biotech Completes Patient Enrollment to TASQ Clinical Phase II study (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090608/0508410.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/2117481398</guid><pubDate>Mon, 8 Jun 2009 06:30:00 Etc/GMT</pubDate></item><item><title>Active Biotech Completes Patient Enrollment to ANYARA Phase III Clinical Trial (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090601/0506213.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2242114475</guid><pubDate>Mon, 1 Jun 2009 06:30:00 Etc/GMT</pubDate></item><item><title>Annual General Meeting of Active Biotech AB (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090508/0499290.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/3481449002</guid><pubDate>Fri, 8 May 2009 06:30:00 Etc/GMT</pubDate></item><item><title>Active Biotech presents S100A9 as a target for quinoline compounds (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090428/0495251.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3859124999</guid><pubDate>Tue, 28 Apr 2009 06:40:00 Etc/GMT</pubDate></item><item><title>Active Biotech AB Interim report January-March 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090423/0494037.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2786352409</guid><pubDate>Thu, 23 Apr 2009 06:31:00 Etc/GMT</pubDate></item><item><title>Annual Report 2008 Active Biotech AB (publ) (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090406/0488798.html</link><description></description><guid isPermaLink="false">yahoo_finance/35983456</guid><pubDate>Mon, 6 Apr 2009 07:22:00 Etc/GMT</pubDate></item></channel></rss><!-- c3.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 09:50:41 PST 2009 -->
